EUVIMEDEUVIMED entdecken
ValidierungsstudieVergleichsstudie

Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report

Donna Rowen, Jill Carlton, Emily McDool, Frank G Holz, Nadia Zakaria, Jan H Terheyden, Robert P Finger, MACUSTAR Consortium

Value in Health · 2025

DOI: 10.1016/j.jval.2025.04.2155 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Value in Health, 2025. Verfasst von Donna Rowen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sheffield Centre for Health and Related Research, University of Sheffield, England, UK. Electronic address: d.rowen@sheffield.ac.uk. Hauptthemen laut MEDLINE: Macular Degeneration, Psychometrics, Quality of Life, Vision Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The Vision Impairment in Low Luminance-Utility Index (VILL-UI) is a novel preference-weighted measure for use in patients with age-related macular degeneration (AMD). No evidence exists on its psychometric performance nor its performance in comparison with the generic preference-weighted measure, EQ-5D-5L, commonly used in economic evaluation. This study compares the psychometric performance of VILL-UI with EQ-5D-5L in patients with AMD. METHODS: Assessments of feasibility, convergent/divergent validity, and known-group validity of VILL-UI and EQ-5D-5L are undertaken using MACUSTAR data at baseline, 12, 24, and 36 months. Analyses are undertaken separately using UK and German preference weights for both measures. RESULTS: The sample with complete responses (n = 586) had mean age 71.9 years (standard deviation 6.9), 65.2% women, with predominantly intermediate AMD (87.2%). VILL-UI and EQ-5D-5L are feasible for completion, although VILL-UI has fewer usable responses due to its response options (baseline 89% vs 100%). EQ-5D-5L has high ceiling effects, with around one-third of participants reporting the best health state compared with under 8% for VILL-UI. Convergent validity between EQ-5D-5L and VILL-UI utilities and dimensions in which a relationship is expected is low, with divergent validity demonstrated where expected. VILL-UI detected statistically significant differences in known groups for visual acuity, visual function, and AMD stage across most time points, with little evidence of known-group validity for EQ-5D-5L. CONCLUSIONS: VILL-UI is appropriate for use in future AMD studies to inform economic evaluation. VILL-UI has superior performance to EQ-5D-5L for known-group validity and has fewer ceiling effects but has fewer usable responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationPsychometricsQuality of LifeVision DisordersHumansFemaleAgedMaleReproducibility of ResultsSurveys and QuestionnairesMiddle AgedAged, 80 and overUnited KingdomVisual AcuityFeasibility StudiesGermany

Stichwörter der Autor:innen

EQ-5D-5LVILL-UIage-related macular degenerationpsychometrics

Autor:innen und Institutionen

  • Sheffield Centre for Health and Related Research, University of Sheffield, England, UK. Electronic address: d.rowen@sheffield.ac.uk.
  • Sheffield Centre for Health and Related Research, University of Sheffield, England, UK.
  • Department of Ophthalmology, University of Bonn, Germany.
  • Novartis AG, Basel, Switzerland.

Förderung

  • Innovative Medicines Initiative

Zitieren

APA

Rowen, D., Carlton, J., McDool, E., Holz, F. G., Zakaria, N., Terheyden, J. H., Finger, R. P., & MACUSTAR Consortium (2025). Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report. Value in Health. https://doi.org/10.1016/j.jval.2025.04.2155

Vancouver

Rowen D, Carlton J, McDool E, Holz FG, Zakaria N, Terheyden JH, et al. Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report. Value in Health. 2025. doi:10.1016/j.jval.2025.04.2155

BibTeX
@article{Rowen2025,
  author = {Rowen, Donna and Carlton, Jill and McDool, Emily and Holz, Frank G and Zakaria, Nadia and Terheyden, Jan H and Finger, Robert P and MACUSTAR Consortium, MACUSTAR Consortium},
  title = {Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report},
  journal = {Value in Health},
  year = {2025},
  doi = {10.1016/j.jval.2025.04.2155}
}
Kostenlos starten →